23 sources checked · 2 source groups included · 1h ago
Most headlines factually report the FDA approval, while one emphasizes the novelty and future availability of the vaccine.
STILL WATCHING
As of August 6, 2026 at 12:43 PM, this is how Optics News reads the wording differences in this story.
23 sources across 2 bias buckets agree on the event.
20/99 — the outlets mostly agree on the headline takeaway.
WHAT EACH SIDE EMPHASIZED
The Independent · Center-left · News report
The Hill · Center · News report
Optics keeps watching for pickup.
SEE THE HEADLINES
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the shot for two separate age gro...
The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same m RNA technology that was key to ending the COVID-19 pandemic
The FDA has approved Moderna's flu vaccine for people aged 50 and older, marking the first approval of a messenger RNA-based vaccine for seasonal flu.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The agency approved the shot for two separate age groups: People age 50 to 64, and for 65 years and older.
A younger and higher-educated base were pivotal to Abdul El Sayed’s Senate Primary win, an analysis shows.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
Plus, what happens when you have an A.I. boss.
SOURCE MAP CHANGES
Aug 6, 10:00 AM: The New York Times joined the source map.
Aug 6, 10:39 AM: The Hill joined the source map.
Aug 6, 10:58 AM: WDSU New Orleans (Hearst) joined the source map.
Aug 6, 10:58 AM: WCVB Boston (Hearst) joined the source map.
Now: Wording Gap is 20/99 and story health is live match · 23 sources · 2 buckets · comparable news format.